» Articles » PMID: 26330830

Aquaporin-4 Gene Silencing Protects Injured Neurons After Early Cerebral Infarction

Overview
Date 2015 Sep 3
PMID 26330830
Citations 10
Authors
Affiliations
Soon will be listed here.
Abstract

Aquaporin-4 regulates water molecule channels and is important in tissue regulation and water transportation in the brain. Upregulation of aquaporin-4 expression is closely related to cellular edema after early cerebral infarction. Cellular edema and aquaporin-4 expression can be determined by measuring cerebral infarct area and apparent diffusion coefficient using diffusion-weighted imaging (DWI). We examined the effects of silencing aquaporin-4 on cerebral infarction. Rat models of cerebral infarction were established by occlusion of the right middle cerebral artery and siRNA-aquaporin-4 was immediately injected via the right basal ganglia. In control animals, the area of high signal intensity and relative apparent diffusion coefficient value on T2-weighted imaging (T2WI) and DWI gradually increased within 0.5-6 hours after cerebral infarction. After aquaporin-4 gene silencing, the area of high signal intensity on T2WI and DWI reduced, relative apparent diffusion coefficient value was increased, and cellular edema was obviously alleviated. At 6 hours after cerebral infarction, the apparent diffusion coefficient value was similar between treatment and model groups, but angioedema was still obvious in the treatment group. These results indicate that aquaporin-4 gene silencing can effectively relieve cellular edema after early cerebral infarction; and when conducted accurately and on time, the diffusion coefficient value and the area of high signal intensity on T2WI and DWI can reflect therapeutic effects of aquaporin-4 gene silencing on cellular edema.

Citing Articles

Revolutionizing Stroke Care: Nanotechnology-Based Brain Delivery as a Novel Paradigm for Treatment and Diagnosis.

Balaji P, Bhimrao L, Yadav A Mol Neurobiol. 2024; 62(1):184-220.

PMID: 38829514 DOI: 10.1007/s12035-024-04215-3.


Cellular and Molecular Pathophysiology of Traumatic Brain Injury: What Have We Learned So Far?.

Freire M, Rocha G, Bittencourt L, Falcao D, Lima R, Cavalcanti J Biology (Basel). 2023; 12(8).

PMID: 37627023 PMC: 10452099. DOI: 10.3390/biology12081139.


The Glymphatic System: A Novel Therapeutic Target for Stroke Treatment.

Lv T, Zhao B, Hu Q, Zhang X Front Aging Neurosci. 2021; 13:689098.

PMID: 34305569 PMC: 8297504. DOI: 10.3389/fnagi.2021.689098.


Effects of the methanol fraction of modified Seonghyangjeongki-san water extract on transient ischaemic brain injury in mice.

Kang E, Cho S, Lim C, Lee B, Kim Y, Kim K Pharm Biol. 2021; 59(1):840-853.

PMID: 34184969 PMC: 8245089. DOI: 10.1080/13880209.2021.1941130.


Methylene blue ameliorates brain edema in rats with experimental ischemic stroke via inhibiting aquaporin 4 expression.

Shi Z, Fang Q, Chen Y, Xu L, Wu M, Jia M Acta Pharmacol Sin. 2020; 42(3):382-392.

PMID: 32665706 PMC: 8027449. DOI: 10.1038/s41401-020-0468-5.


References
1.
Grange-Messent V, Raison D, Bouchaud C . Compared effects of extracellular K+ ions and soman, a neurotoxic, on cerebral astrocyte morphology. An in vitro study. J Submicrosc Cytol Pathol. 1996; 28(2):151-9. View

2.
Nag S, Manias J, Stewart D . Pathology and new players in the pathogenesis of brain edema. Acta Neuropathol. 2009; 118(2):197-217. DOI: 10.1007/s00401-009-0541-0. View

3.
Kleindienst A, Fazzina G, Amorini A, Dunbar J, Glisson R, Marmarou A . Modulation of AQP4 expression by the protein kinase C activator, phorbol myristate acetate, decreases ischemia-induced brain edema. Acta Neurochir Suppl. 2006; 96:393-7. DOI: 10.1007/3-211-30714-1_81. View

4.
Friedman B, Schachtrup C, Tsai P, Shih A, Akassoglou K, Kleinfeld D . Acute vascular disruption and aquaporin 4 loss after stroke. Stroke. 2009; 40(6):2182-90. PMC: 2753985. DOI: 10.1161/STROKEAHA.108.523720. View

5.
Lu H, Hu H, He Z, Han X, Chen J, Tu R . Therapeutic imaging window of cerebral infarction revealed by multisequence magnetic resonance imaging: An animal and clinical study. Neural Regen Res. 2014; 7(31):2446-55. PMC: 4200719. DOI: 10.3969/j.issn.1673-5374.2012.31.006. View